...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: US to shell out $1.2B for sup­plies of Mer­ck­'s po­ten­tial Covid-19 an­tivi­ral.

One little wrinkle.......Resverlogix still has to Start the trial!!!  It's amazing how all these other companies with vaccines and therapeutics manage to partner up with a bigger player and make much faster headway than RVX. Perhaps someday we will learn of a good reason for RVX taking this excruciatingly slow path, right now they just look incompetent.  The market would seem to agree. 

Share
New Message
Please login to post a reply